Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dry powder aerosol containing muco-inert particles for excipient enhanced growth pulmonary drug delivery

Nanomedicine Nanotechnology Biology and Medicine(2020)10.1016/j.nano.2020.102262Source: DataRank Database

Dry powder aerosol containing muco-inert particles for excipient enhanced growth pulmonary drug delivery is a research paper published in Nanomedicine Nanotechnology Biology and Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.43)OA: greenTopics (41)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Amr Hassan ORCID,Tuo Meng ORCID,Lihua Lou ORCID,Jonathan Ma ORCID,Russell Simmers

Live enrichment

PubMed:32623017 PMC:PMC7508849 OpenAlex:https://openalex.org/W3039648328

NEI NIH HHS

Grant: R01 EY027827

NICHD NIH HHS

Grant: R01 HD087339

FDA HHS

Grant: HHSF223201810114C

NIAID NIH HHS

Grant: R01 AI146160

NIDA NIH HHS

Grant: UG3 DA048768

National Institutes of Health

Cystic Fibrosis Foundation Therapeutics

Food and Drug Administration

FWCI

1.43

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7508849

publisherhttps://api.elsevier.com/content/article/PII:S1549963420301167?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1549963420301167?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.nano.2020.102262

Fields of Study

Inhalation and Respiratory Drug DeliveryCystic Fibrosis Research AdvancesNeonatal Respiratory Health Research

MeSH Terms

Administration, InhalationCystic FibrosisExcipientsHumansLungLung DiseasesMucusPolyethylene GlycolsPolystyrenesDrug Delivery SystemsNanoparticlesDry Powder Inhalers

Keywords

ExcipientDry-powder inhalerAerosolizationAerosolInertMaterials scienceDrug deliverySputumNebulizerCystic fibrosisChemistryChromatographyInhalerMedicineNanotechnologyInhalationAsthmaAnesthesiaOrganic chemistryPathologyImmunologySpray DryingDry Powder InhalerMucus PenetrationMultiple Particle TrackingCf Sputum

Sustainable Development Goals

SDG 0: Good health and well-being